Defence Therapeutics Inc.
Defence Therapeutics Inc.
CSE Index:
Currency:
Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
604-753-8834Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.SEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
604-753-8834Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
54725370Reserved for Issuance:
6437785Company Officers
P. Joseph Meagher, Chief Financial Officer
Sebastien Plouffe, President and Chief Executive Officer
Arnab De, CFO
News Releases
Bulletins
06/05/2021
2021-0505 – New Listing - Defence Therapeutics Inc. (DTC)
Le 6 mai/May 2021
The common shares of Defence Therapeutics Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
